MVP portfolio company Prolupin, the innovative plant-based protein company based in Grimmen, Germany, today announced the extension of its groth financing round with the investment of the European Circular Bioeconomy Fund.

SHARE THIS ARTICLE
SOCIALICON

The European Circular Bioeconomy Fund (ECBF) is a new pan-European fund that invests in growth companies in the bioeconomy and circular bioeconomy with equity and mezzanine financings. The ECBF is backed by the European Investment Bank (EIB) as the cornerstone investor and by Hauck & Aufhäuser Fund Services S.A. administered in Luxembourg. Backed by the European Investment Bank (EIB) and managed by Hauck & Aufhäuser Fund Services S.A. in Luxembourg, ECBF is the first growth-fund fund exclusively dedicated to the bioeconomy in Europe that focus on catalyzes sustainable innovations.

Since the launch of its vegan brand Made with LUVE in 2015, Prolupin has enjoyed exceptional annual growth. The new financing now enables the company to address the mass market for further growth and international expansion.

In addition to the existing investors, Munich Venture Partners and eCAPITAL, the renowned investors Capricorn Partners and Novax have already participated in the financing round in spring.

The Capricorn Partners, Novax, and ECBF investment brings a broad mix of technology expertise and trade network resources to Prolupin as it seeks to grow its plant-based offerings from lupines both B2B and B2C, including the non-dairy yoghurts, milks, ice creams and cream cheeses on the European market under the vegan Made with LUVE brand.

 

“The ECBF funding will make an important contribution to accelerate the growth of Prolupin within B2B and B2C. The research & development, marketing and distribution we are now able to deploy over the coming years will put our unique Lupine Protein Isolate (LPI) as well as the vegan Made with LUVE brand center stage for customers and consumers aiming for a healthy, sustainable ingredient and lifestyle.”

Malte Stampe (CEO, Prolupin GmbH)

Reiner Kuester, Chairman of the Supervisory Board of Prolupin, stressed: “We are pleased to welcome the ECBF and the expertise it brings to the Advisory Board. With its international network and its focus on sustainability, the ECBF can significantly contribute to strengthening Prolupin’s position as a strong player in the fast-growing market of plant-based foods.

Michael Brandkamp, Managing Partners at ECBF, says: ” Prolupin is a fast-growing plant-based protein company with its successfully established dairy-alternatives brand made with LUVE. The growth in consumer demand for healthier food with a reduced environmental footprint will be long-lasting. With its lupine-based protein Prolupin is well positioned to capture a significant share in this market and to contribute to making our societies more sustainable.”

The investment bank Bryan, Garnier & Co was appointed as exclusive financial advisor for the transaction.